SCHEMBL5147176

SCHEMBL5147176

C=CC1CC(C=C)C(C=C)C1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9461780 0.86
SCHEMBL712165 0.82 ALDH1A1 (0.32) ALDH1A1ALOX15
SCHEMBL2218103 0.82 ALDH1A1 (0.32) ALDH1A1ALOX15
SCHEMBL16004725 0.82 ALDH1A1 (0.32) ALDH1A1ALOX15
SCHEMBL16004723 0.82 ALDH1A1 (0.32) ALDH1A1ALOX15
SCHEMBL710328 0.82 ALDH1A1 (0.32) ALDH1A1ALOX15
SCHEMBL114466 0.82 ALDH1A1 (0.32) ALDH1A1ALOX15
SCHEMBL215376 0.81 ALDH1A1 (0.36) ALDH1A1ALOX15
SCHEMBL17798828 0.81
SCHEMBL5147182 0.81 TDP1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5264606-A Catalytic reaction of ethylene with norbornene UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1993-11-23 US claimed
EP-0480528-A1 Process for the preparation of polyvinyl compounds UNION CARBIDE CHEMICALS AND PLASTICS COMPANY, INC. (US) 1992-04-15 EP claimed
EP-2912027-B1 NOVEL EPOXIDE COMPOUNDS: 1,3-DIOXIRANYLCYCLOPENTANE DERIVATIVES BLUE CUBE IP LLC (US) 2019-09-11 EP disclosed
US-9505731-B2 Epoxide compound BLUE CUBE IP LLC (US) 2016-11-29 US disclosed
EP-2912027-A1 NOVEL EPOXIDE COMPOUNDS: 1,3-DIOXIRANYLCYCLOPENTANE DERIVATIVES Dow Global Technologies LLC (US) 2015-09-02 EP disclosed
US-20150225359-A1 NOVEL EPOXIDE COMPOUND BLUE CUBE IP LLC 2015-08-13 US disclosed
WO-2014066717-A1 NOVEL EPOXIDE COMPOUNDS: 1,3-DIOXIRANYLCYCLOPENTANE DERIVATIVES DOW GLOBAL TECHNOLOGIES LLC (US) 2014-05-01 WO disclosed
US-20070066782-A1 Film-forming composition, insulating film and electronic device using the same FUJI PHOTO FILM CO., LTD. 2007-03-22 US disclosed
US-5514827-A CROSSLINKING SILICONE RUBBERS, CAULKS, SEALS OSI SPECIALTIES, INC. (US) 1996-05-07 US disclosed
US-5264606-A Catalytic reaction of ethylene with norbornene UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1993-11-23 US disclosed
EP-0480528-A1 Process for the preparation of polyvinyl compounds UNION CARBIDE CHEMICALS AND PLASTICS COMPANY, INC. (US) 1992-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150225359-A1 NOVEL EPOXIDE COMPOUND OXER1, EPHX1, PTGER1 ALDH1A1 1256/4885ALOX15 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.